Tiny Corbus looks to take on Vertex with experimental lung drug

(Reuters) - Corbus Pharmaceuticals Holdings Inc's experimental drug for cystic fibrosis, a rare lung-scarring disease, could be a real money spinner and pose a challenge to rival Vertex Pharmaceuticals Inc's successful treatment, Kalydeco.

Source: Reuters: Health - May 4, 2015 Category: Consumer Health News Tags: healthNews Source Type: news